Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy.
about
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesImmunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesClinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).Peripheral neuropathy in cancer patients.Diagnosis and management of neuropathies associated with plasma cell dyscrasias.Sensorimotor polyneuropathy and monoclonal IgM: a review of clinical and immunological features.Peripheral neuropathies in Waldenström's macroglobulinaemia.A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group.Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study GroupPathogenesis and Treatment of Anti-MAG Neuropathy.HCV-related central and peripheral nervous system demyelinating disorders.Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.Morphological changes at paranodes in IgM paraproteinaemic neuropathy.Clinical immunology.Inflammatory demyelinating lesions in two patients with IgM monoclonal gammopathy and polyneuropathy.Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy.Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.
P2860
Q24197877-4E2D03A6-7587-4CDC-94F8-AAFD6312164FQ24243918-9E963017-87B7-4BEF-B6C4-B73189A0F132Q33762563-A500FF72-6FA4-4D8A-9D5E-C88F74DA2F8DQ34280846-BE39B92B-8C63-4225-8E21-77DE960C0130Q34555067-D88109FA-F138-4E02-8599-847FB870237AQ35158392-888E4057-F4C5-4721-8422-6D3478C1CD90Q36142494-FE9DBB0D-D158-4612-98F5-52F32568AC61Q36316836-B54E2939-0501-46D0-A977-14A0F5ECC6B4Q36484465-3C8E62C5-924E-4DF0-B2DE-D9AF6803398AQ36880650-89A24F97-34D7-4A73-BF38-3D4E0B759025Q37788996-76159D41-2B55-407A-9EF0-E1B5AB4E01D8Q38246873-32D7A5FE-BDE4-4644-B429-52F223462BEFQ38971983-5F184931-8DF9-46E2-9063-A9FFD7D6E827Q41140039-D7E29D7E-CECC-45EE-9CFB-A1D0FF6D4252Q41843290-49D4FE2F-31EE-49DA-B2E3-355F16B2DEA8Q42149079-34D387ED-87D0-47C1-87AB-D4D2CBF7BBC1Q43083591-014D1D08-70DF-4C7E-93AF-1EB7D806115AQ50197158-52D1D70C-94CE-4398-AFCE-BDF028822F87
P2860
Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Complement-mediated demyelinat ...... gammopathy and polyneuropathy.
@en
Complement-mediated demyelinat ...... gammopathy and polyneuropathy.
@nl
type
label
Complement-mediated demyelinat ...... gammopathy and polyneuropathy.
@en
Complement-mediated demyelinat ...... gammopathy and polyneuropathy.
@nl
prefLabel
Complement-mediated demyelinat ...... gammopathy and polyneuropathy.
@en
Complement-mediated demyelinat ...... gammopathy and polyneuropathy.
@nl
P2093
P1476
Complement-mediated demyelinat ...... gammopathy and polyneuropathy.
@en
P2093
Manfredini E
Mollnes TE
Nardelli E
Nobile-Orazio E
P304
P356
10.1056/NEJM199003083221002
P407
P577
1990-03-01T00:00:00Z